Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Retracted] Upregulation of miR‑183‑5p is responsible for the promotion of apoptosis and inhibition of the epithelial‑mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
Yan H, Sun BM, Zhang YY, Li YJ, Huang CX, Feng FZ, Li C. Yan H, et al. Among authors: feng fz. Int J Mol Med. 2024 Mar;53(3):21. doi: 10.3892/ijmm.2024.5345. Epub 2024 Jan 12. Int J Mol Med. 2024. PMID: 38214365 Free PMC article.
Comparing biweekly single-dose actinomycin D with multiday methotrexate therapy for low-risk gestational trophoblastic neoplasia (FIGO Score 0-4): study protocol for a prospective, multicentre, randomized trial.
Jiang F, Mao MY, Xiang Y, Lu X, Guan CL, Jiao LZ, Wan XR, Feng FZ, Ren T, Yang JJ, Zhao J. Jiang F, et al. Among authors: feng fz. BMC Cancer. 2023 Aug 23;23(1):784. doi: 10.1186/s12885-023-11225-2. BMC Cancer. 2023. PMID: 37612621 Free PMC article.
Combining serum peptide signatures with International Federation of Gynecology and Obstetrics (FIGO) risk score to predict the outcomes of patients with gestational trophoblastic neoplasia (GTN) after first-line chemotherapy.
Wang F, Wang ZR, Ding XS, Yang H, Guo Y, Su H, Wan XR, Wang LJ, Jiang XY, Xu YH, Chen F, Cui W, Feng FZ. Wang F, et al. Among authors: feng fz. Front Oncol. 2022 Oct 21;12:982806. doi: 10.3389/fonc.2022.982806. eCollection 2022. Front Oncol. 2022. PMID: 36338720 Free PMC article.
48 results